| US: Vaccines on horizon for AIDS, Alzheimer's, herpes
Found: Wed Nov 18 01:02:41 2009 PST
Source: Pique Newsmagazine (CN BC)
Copyright: Pique Publishing Inc.
Contact: edit@piquenewsmagazine.com
Website: http://www.piquenewsmagazine.com/
Details: http://www.mapinc.org/media/2356
Webpage: http://www.washingtonpost.com/wp-dyn/conte...
Newshawk: http://drugpolicycentral.com/bot/
| |
Vaccines on horizon for AIDS, Alzheimer's, herpes Vaccines on horizon for AIDS, Alzheimer's, herpes - washingtonpost.com
TODAY'S NEWSPAPER
E-mail
COMMENT
0 Comments
Your browser's settings may be preventing you from commenting on and viewing comments about this item. See instructions for fixing the problem.
Discussion Policy
CLOSE
Who's Blogging
; Links to this article
By LINDA A. JOHNSON The Associated Press
Wednesday, November 18, 2009; 3:52 AM
MARIETTA, Pa. -- Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.
Many could be on the market in five years or less.
Contrast that with five years ago, when so many companies had abandoned the vaccine business that half the U.S. supply of flu shots was lost because of factory contamination at one of the two manufacturers left.
Vaccines are no longer a sleepy, low-profit niche in a booming drug industry. Today, they're starting to give ailing pharmaceutical makers a shot in the arm.
The lure of big profits, advances in technology and growing government support has been drawing in new companies, from nascent biotechs to Johnson & Johnson. That means recent remarkable strides in overcoming dreaded diseases and annoying afflictions likely will continue.
"Even if a small portion of everything that's going on now is successful in the next 10 years, you put that together with the last 10 years (and) it's going to be characterized as a golden era," says Emilio Emini, Pfizer Inc.'s head of vaccine research.
Vaccines now are viewed as a crucial path to growth, as drugmakers look for ways to bolster slowing prescription medicine sales amid intensifying generic competition and government pressure to cut down prices under the federal health overhaul.
Unlike medicines that treat diseases, vaccines help prevent infections by revving up the body's natural immune defenses against invaders. They are made from viruses, bacteria or parts of them that have been killed or weakened so they generally can't cause an infection.
Investment in partnerships and other deals to develop and manufacture vaccines has been on a tear - and accelerating since the swine flu pandemic began. Billions in government grants are bringing better, faster ways to develop and manufacture vaccines. Rising worldwide emphasis on preventive health care, plus the advent of the first multibillion-dollar vaccines, have further boosted their appeal.
While prescription drug sales are forecast to rise by a third in five years, vaccine sales should double, from $19 billion last year to $39 billion in 2013, according to market research firm Kalorama Information. That's five times the $8 billion in vaccine sales in 2004.
"What was essentially 25 years ago a rounding error now has become real money," says Robin Robertson, director of the U.S. Biomedical Advanced Research Development Authority.
That jump is due to a couple of new blockbuster vaccines and rising use of existing ones. The government's list of recommended vaccines for children since has more than doubled since 1985 to 17. It now also calls for a half-dozen vaccines for everyone over 18 and up to four more for some adults.
CONTINUED 1 2 Next }
EvriLinks powered by
(c) 2009 The Associated Press
Featured Advertiser Links
* Lawsuit: Hydroxycut Liver, Cochlear Implants, Zicam Recall, Yaz}}
* Attorney: Mesothelioma, Lawyer, Cancer from Asbestos, Lung Cancer}}
* Debt destroying your day?New Debt Wise helps you decrease your debt!}}
* Create Jobs. Help the Economy. Join the National Gateway.}}
* Russia Now: In-Depth Coverage of Russia News, Business, and More.}}
The Washington Post Company: Information and Other Post Co. Websites
Digg
Facebook
I thought this page was interesting because:
| re:0.88 st:0.02 fo:0 s:0 d:2.28 c:0.03 db:0.026 a:0.37 m:0.1 t:5.23 (f) |
|